HEATHER WHITTINGTON: Open Payments
NPI 1124479043 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$689 in 44 payments from 11 companies in 2025. Trend: 2023 $359 · 2024 $548 · 2025 $689
Food & beverage: $689
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $233 |
| Ardelyx, Inc. | 14 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| Celltrion USA Inc. | 2 | $48 |
| Ipsen Biopharmaceuticals, Inc | 2 | $43 |
| Novo Nordisk Inc | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
| Madrigal Pharmaceuticals | 1 | $17 |
Products named: IBSRELA, RINVOQ, ENTYVIO, XIFAXAN, VEGZELMA, SKYRIZI, IQIRVO, VIBERZI.
Industry payments across WV — which companies pay providers there.
